Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
Gamma globulins were obtained from rabbits hyperimmunized with the filamentous hemagglutinin (FHA) or the leukocytosis-promoting factor hemagglutinin (LPF.HA) of Bordetella pertussis. Double immunodiffusion analyses showed the antibodies to be highly specific for the homologous antigen. Intraperitoneal injection of anti-FHA or anti-LPF.HA into 10-day-old ICR mice 30 min before aerosol challenge with B. pertussis protected the mice from disease as evidenced by survival and a normal rate of gain in body weight. Both anti-LPF.HA and anti-FHA enhanced the clearance of B. pertussis from the lung and prevented leukocytosis which normally occurs after aerosol infection of mice with B. pertussis. Anti-LPF.HA, but not anti-FHA, neutralized the leukocytosis-promoting and histamine-sensitizing activities of LPF.HA when incubated with the purified protein in vitro. Anti-FHA, but not anti-LPF.HA, prevented the attachment of B. pertussis to mammalian cells (HeLa and Vero) in culture.
D000818:Animals; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial / Q000032:analysis*; D001886:Bordetella pertussis / Q000276:immunology*; D004195:Disease Models, Animal; D006388:Hemagglutinins / Q000276:immunology*; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000276:immunology*; D008222:Lymphokines / Q000276:immunology*; D051379:Mice; D037342:Pertussis Toxin; D010567:Pertussis Vaccine / Q000032:analysis; D011817:Rabbits; D010566:Virulence Factors, Bordetella
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D006388:Hemagglutinins; D007376:Interleukin-2; D008222:Lymphokines; D010567:Pertussis Vaccine; D010566:Virulence Factors, Bordetella; D037342:Pertussis Toxin